Pertussis (Whooping Cough) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Pertussis, also known as whooping cough, is a highly contagious respiratory disease. It is caused by the bacterium Bordetella pertussis. Symptoms include runny nose, nasal congestion, sneezing, red, watery eyes, and dry cough. Treatment includes antibiotics.
The Pertussis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Pertussis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report offers an overview of key players involved in therapeutic development for Pertussis and features dormant and discontinued projects.
Pertussis Pipeline Drugs Market Segmentation by Targets
Some of the targets of the Pertussis pipeline drugs market are Pertussis Toxin, Diphtheria Toxin, Tetanus Toxin, Haemophilus influenzae Lipooligosaccharide, and Others. Pertussis Toxin leads this segment of the Pertussis pipeline drugs market.
Pertussis Pipeline Drugs Market Analysis, by Targets
For more Pertussis pipeline drugs market target insights, download a free report sample
Pertussis Pipeline Drugs Market Segmentation by Mechanisms of Action
Some of the key mechanisms of action of the Pertussis pipeline drugs market are Bordetella pertussis Pertussis Toxin S1 Subunit Inhibitor and Pertussis Toxin Inhibitor. Both MoA are at par in the Pertussis pipeline drugs market in terms of MoA.
Pertussis Pipeline Drugs Market Analysis, by Mechanisms of Action
For more mechanisms of action insights into the Pertussis pipeline drugs market, download a free report sample
Pertussis Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the Pertussis pipeline drugs market are intramuscular, nasal, subcutaneous, and oral. Intramuscular leads the Pertussis pipeline drugs market in terms of RoA.
Pertussis Pipeline Drugs Market Analysis, by Routes of Administration
For more routes of administration insights into the Pertussis pipeline drugs market, download a free report sample
Pertussis Pipeline Drugs Market Segmentation by Molecule Types
The molecule types in the Pertussis pipeline drugs market are toxoid vaccine, inactivated vaccine, subunit vaccine, vaccine, and others. Toxoid Vaccine leads the Pertussis pipeline drugs market in terms of molecule types.
Pertussis Pipeline Drugs Market Analysis, by Molecule Types
For more molecule-type insights into the Pertussis pipeline drugs market, download a free report sample
Pertussis Pipeline Drugs Market - Competitive Landscape
Some of the key companies in the Pertussis pipeline drugs market are CanSino Biologics Inc, AIM Vaccine Co Ltd, KM Biologics Co Ltd, Serum Institute of India Pvt Ltd, and Others. CanSino Biologics Inc has the highest number of products under development.
Pertussis Pipeline Drugs Market Analysis, by Companies
To know more about the Pertussis pipeline drugs market companies, download a free report sample
Pertussis Pipeline Drugs Market Report Overview
Key Targets | Pertussis Toxin, Diphtheria Toxin, Tetanus Toxin, Haemophilus influenzae Lipooligosaccharide, and Others |
Key Mechanisms of Action | Bordetella pertussis Pertussis Toxin S1 Subunit Inhibitor and Pertussis Toxin Inhibitor |
Key Routes of Administration | Intramuscular, Nasal, Subcutaneous, and Oral |
Key Molecule Types | Toxoid Vaccine, Inactivated Vaccine, Subunit Vaccine, Vaccine, and Others |
Key Companies | CanSino Biologics Inc, AIM Vaccine Co Ltd, KM Biologics Co Ltd, Serum Institute of India Pvt Ltd, and Others |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Pertussis.
- The pipeline guide reviews pipeline therapeutics for Pertussis by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Pertussis therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Pertussis therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Pertussis
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Pertussis.
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding the Pertussis pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understanding from the know-how what drove them from the pipeline.
Beijing Minhai Biotechnology Co Ltd
Beijing Tiantan Biological Products Co Ltd
Bharat Biotech Ltd
Biken Co Ltd
Biological E Ltd
BioNet-Asia Co Ltd
Boryung Pharmaceutical Co Ltd
CanSino Biologics Inc
Changchun Bcht Biotechnology Co Ltd
Chengdu Olymvax Biopharmaceuticals Inc
Chongqing Zhifei Biological Products Co Ltd
Gamaleya Federal Research Center of Epidemiology and Microbiology
GC Biopharma Corp
GSK plc
ILiAD Biotechnologies LLC
Intravacc BV
KM Biologics Co Ltd
LG Chem Ltd
Novo Medi Sciences Pvt Ltd
Panacea Biotec Ltd
Sanofi
Serum Institute of India Pvt Ltd
Shantha Biotechnics Pvt Ltd
Suzhou Weichao Biotechnology Co Ltd
Theriva Biologics Inc
VaxForm LLC
Wuhan Institute of Biological Products Co Ltd
Yunnan Watson Biotechnology Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets of the Pertussis pipeline drugs market?
Some of the targets of the Pertussis pipeline drugs market are Pertussis Toxin, Diphtheria Toxin, Tetanus Toxin, Haemophilus influenzae Lipooligosaccharide, and Others.
-
What are the key mechanisms of action in the Pertussis pipeline drugs market?
Some of the mechanisms of action of the Pertussis pipeline drugs market are Bordetella pertussis Pertussis Toxin S1 Subunit Inhibitor and Pertussis Toxin Inhibitor.
-
What are the key routes of administration in the Pertussis pipeline drugs market?
The key routes of administration in the Pertussis pipeline drugs market are intramuscular, nasal, subcutaneous, and oral.
-
What are the key molecule types in the Pertussis pipeline drugs market?
The molecule types in the Pertussis pipeline drugs market are toxoid vaccine, inactivated vaccine, subunit vaccine, vaccine, and others.
-
Which are the leading companies in the Pertussis pipeline drugs market?
Some of the leading companies in the Pertussis pipeline drugs market are CanSino Biologics Inc, AIM Vaccine Co Ltd, KM Biologics Co Ltd, Serum Institute of India Pvt Ltd, and Others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.